drugset / Trial / NCT05360342
Incorporation of Vitamin K Into Uremic Lipoproteins
NaSingle-groupOpen-labelBasic science
Summary
Chronic kidney disease (CKD) patients have an increased cardiovascular risk with corresponding cardiovascular calcifications. CKD patients exhibit a functional vitamin K deficiency. Calcification can be prevented by vitamin K intake. The aim of this study is to investigate the cause for the vitamin K deficiency beyond a diminished dietary vitamin K uptake.
Timeline
- Start
- 2020-03-31
- Primary completion
- 2021-07-15
- Completion
- 2021-09-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Menatetrenone | Unknown | 1000 ug | — |
| Subject | Vitamin K | Unknown | 1000 ug | — |
| Subject | menaquinone-7 | Small molecule | 200 ug | — |